Freshfields and Camerons lead on €9.6bn pharma acquisition
Freshfields Bruckhaus Deringer and CMS Cameron McKenna have advised on the largest European private equity deal since before the global financial crisis, worth €9.6bn (£8.4bn). The two law firms have advised as Japanese pharma company Takeda makes a move into the European market with the debt-free purchase of Swiss-based drug-maker Nycomed from its private equity owners.
Freshfields Bruckhaus Deringer and CMS Cameron McKenna have advised on the largest European private equity deal since before the global financial crisis, worth €9.6bn (£8.4bn).
This premium content is reserved for
Legal Week Subscribers.
A PREMIUM SUBSCRIPTION PROVIDES:
- Trusted insight, news and analysis from the UK and across the globe
- Connections to senior business lawyers within the leading law firms and legal departments
- Unique access to ALM's unrivalled, market-leading reporting in the US and Asia and cutting-edge research, including Legal Week's UK Top 50 and Global 100 rankings
- The Legal Week Daily News Alert, Editor's Highlights, and Breaking News digital newsletters and more, plus a choice of over 70 ALM newsletters
- Optimized access on all of your devices: desktop, tablet and mobile
- Complete access to the site's full archive of more than 56,000 articles
Already have an account? Sign In Now
For enterprise-wide or corporate enquiries, please contact Paul Reeves on Preeves@alm.com or call on +44 (0) 203 875 0651